阿德福韦
前药
医学
药理学
临床试验
病毒学
乙型肝炎病毒
内科学
病毒
拉米夫定
出处
期刊:PubMed
日期:2007-08-01
卷期号:8 (8): 682-90
被引量:5
摘要
Metabasis Therapeutics Inc (previously Ribapharm Inc) is developing pradefovir, an oral liver-targeting prodrug of adefovir developed using its HepDirect technology, for the potential treatment of HBV infection. Phase II clinical trials of pradefovir have been completed.
科研通智能强力驱动
Strongly Powered by AbleSci AI